Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

20.07
-0.6700-3.23%
Post-market: 20.980.9105+4.54%19:34 EDT
Volume:975.55K
Turnover:19.59M
Market Cap:1.15B
PE:-10.30
High:20.65
Open:20.42
Low:19.76
Close:20.74
52wk High:40.10
52wk Low:16.67
Shares:57.27M
Float Shares:54.47M
Volume Ratio:0.78
T/O Rate:1.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9478
EPS(LYR):-1.7207
ROE:-30.24%
ROA:-14.75%
PB:3.38
PE(LYR):-11.66

Loading ...

Procept BioRobotics Q2 Net Loss Widens to $26.86 Million; Revenue Rises 19% to $94.5 Million

Reuters
·
Aug 05

Procept BioRobotics Q2 Revenue Beats Estimates on Hydros Demand

Reuters
·
Aug 05

PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

Benzinga Earnings
·
Aug 05

Procept Biorobotics Q2 Revenue USD 94.498 Million Vs. IBES Estimate USD 92.9 Million

Reuters
·
Aug 05

Procept Biorobotics Outlook FY Gross Margin 65%

THOMSON REUTERS
·
Aug 05

Procept Biorobotics Outlook FY Revenue USD 390-410 Million

THOMSON REUTERS
·
Aug 05

Procept Biorobotics Corp - Expects Fy2026 U.S. Procedure Volume of 54,000-56,000, up 25%-29%

THOMSON REUTERS
·
Aug 05

PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 05

PROCEPT BioRobotics Lawsuit Puts PRCT Investor Losses in Focus After Alleged Handpiece Demand Disclosures

TIPRANKS
·
Jul 31

Earning Preview: PROCEPT BioRobotics Q2 revenue is expected to increase by 21.59%, and institutional views are bullish

Earnings Agent
·
Jul 29

Medical Robotics Firm PROCEPT BioRobotics Faces Class Action Over Hidden Discount Scheme

Deep News
·
Jul 29

Medical Robotics Company PROCEPT BioRobotics Confronts Securities Fraud Lawsuit Over Discount Disclosure Issues

Deep News
·
Jul 29

Procept BioRobotics Coverage Assumed by UBS at Neutral vs Previous Rating of Buy

Dow Jones
·
Jul 29

UBS Downgrades PROCEPT BioRobotics to Neutral From Buy, Cuts Price Target to $20 From $30

MT Newswires Live
·
Jul 28

Shareholder Action Against Surgical Robotics Firm Over Alleged Deceptive Sales Practices

Deep News
·
Jul 27

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jul 16

Mobia Medical Names Reza Zadno to Board as Independent Director

Reuters
·
Jul 16

Mobia Medical Appoints Reza Zadno, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Jul 16

Procept Biorobotics to Report Q2 Results After Market Close, Host Conference Call

Reuters
·
Jul 15

PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026

GlobeNewswire
·
Jul 15